Literature DB >> 32008640

The Impact of Direct-to-Consumer Genetic Testing on Patient and Provider.

Mary Beth Palko Dinulos1, Stephanie E Vallee2.   

Abstract

Direct-to-consumer genetic testing came on the scene 2 decades ago as a means for allowing consumers to access their genetic information without the involvement of a physician or genetic counselor. Results are delivered directly to the consumer, often leading to misinterpretation and needless medical interventions or false reassurance. Increasingly, we are seeing these patients in our genetics clinics for test interpretation, management guidance and confirmatory genetic testing.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  23andMe; Direct-to-consumer genetic testing; GWAS; SNPs

Mesh:

Year:  2020        PMID: 32008640     DOI: 10.1016/j.cll.2019.11.003

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  2 in total

1.  Association of the V122I Transthyretin Amyloidosis Genetic Variant With Cardiac Structure and Function in Middle-aged Black Adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Arjun Sinha; Yinan Zheng; Drew Nannini; Yishu Qu; Lifang Hou; Sanjiv J Shah; Clyde W Yancy; Elizabeth M McNally; Myriam Fornage; Joao Lima; Donald M Lloyd-Jones; Laura J Rasmussen-Torvik; Sadiya S Khan
Journal:  JAMA Cardiol       Date:  2020-12-23       Impact factor: 14.676

2.  Direct to consumer genetic testing in Denmark-public knowledge, use, and attitudes.

Authors:  Anne-Marie Gerdes; Line Nicolaisen; Egil Husum; Janne Bayer Andersen; Martin Dræbye Gantzhorn; Laura Roos; Birgitte Rode Diness
Journal:  Eur J Hum Genet       Date:  2021-03-01       Impact factor: 5.351

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.